The Food and Drug Administration (FDA) has reminded its stakeholders to submit their financial reports through the agency’s Online Disclosure Reporting System (ODRS), covering the year 2023. FDA’s reminder came following the alleged multi-level marketing scheme involving a pharmaceutical firm and some doctors. “Pursuant to Section 35 (b) of Republic…